Abdullah Salim Al-Karawi, Ali Saad Al-Budairi, Ali M. Atoom. Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia. // Clinical Immunology. – DOI: 10.1016/j.clim.2026.110750. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626000884?dgcid=rss_sd_all
Abdullah Salim Al-Karawi, Ali Saad Al-Budairi, & Ali M. Atoom Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110750
Abdullah Salim Al-Karawi, et al. “Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia.” Clinical Immunology. doi:10.1016/j.clim.2026.110750.
@article{AlKarawi,
title = {Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia},
author = {Al-Karawi, Abdullah Salim and Al-Budairi, Ali Saad and Atoom, Ali M.},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110750},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626000884?dgcid=rss_sd_all}
}